Research News

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

This October the Celiac Disease Foundation hosted physicians and healthcare representatives from more than 15 hospitals for a gluten-free meal to celebrate researchers and officers of NASPGHAN’s Celiac Special Interest Group and the important work they do through their care for our patient community.

A recent study published in The Lancet Journal of Gastroenterology & Hepatology sought to determine the accuracy of blood (serological) tests in celiac disease diagnosis in adults. The results of this study are interesting, to say the least.

For those in our patient community interested in doing a deeper dive on the topic of celiac disease diagnosis, we are happy to provide here expert commentary from Dr. Robert Anderson, MB ChB PhD, on Ciacci et al.